Day: January 9, 2023

Pfizer is working on a Covid generic drug

Pfizer on the works of Covid generic drug, Costco’s sales growth, Beth Bad & Beyond’s bankruptcy, and WWE stock skyrocketing.

January 9, 2023

The content of this website has been prepared by FlexInvest Inc.

FlexInvest is a brand registered by Investium Limited. Investium Limited is authorized and regulated by the Cyprus Securities and Exchange Commission (“CySEC” or the “Commission”) with CySEC License number 421/22. Investium Limited is registered with the Registrar of Companies under number HE412142 and has its registered office at 6 Nikou Georgiou, Office 302, 1095 Nicosia, Cyprus. Information provided on this website cannot and should not be considered as suggestions or recommendations regarding investing, financial, or tax decisions.

Getting “early access” to FlexInvest is defined as signing up with a valid email address for a spot in the waitlist queue. Early access to the waitlist for FlexInvest should in no way be construed as confirmation that a brokerage account with FlexInvest has been opened or will even be approved for opening. Any information about FlexInvest on any FlexInvest website (including www.flexinvest.com and academy.flexinvest.com), the FlexInvest platform, e-mails, or any other communications, are meant for informational purposes only and are not intended as an offer, solicitation, or advertisement for FlexInvest or any goods or services offered by FlexInvest.

Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy, to sell securities, or open a brokerage account in any jurisdiction where FlexInvest is not registered. The content on this website is for general investment education and informational purposes only and does not constitute a complete description of our services. Certain investments are not suitable for all investors and are not available to all our clients. Before investing, consider your investment objectives. Any communication with prospective clients residing in locations where FlexInvest is not registered or licensed shall be limited so as not to trigger registration or licensing requirements. For more information about FlexInvest and all of its related entities and partners, please reach out to [email protected].

Past performance is no guarantee of future results or returns. Diversification does not assure a profit or protect against loss, in a down market. There is always the potential of losing money when you invest in securities or other financial products. Investium recommends that Clients consider their investment objectives and risks before investing.

Margin is not suitable for everyone. Clients should examine their investment objectives, financial resources, experience, risk tolerance, and financial situation to determine whether borrowing against securities and trading on Margin is appropriate. Margin trading involves interest charges and risks, including the potential to lose more than deposited or the need to deposit additional collateral in a falling market.

All logos shown on this website are property of their respective owners and not of FlexInvest or Investium. Representation of names, trademarks, and brands does not imply endorsement; it is used for informational purposes only and cannot and should not be considered as suggestions or recommendations regarding investing. The rights of investors and brand owners are not affected.

To help personalize content, tailor and measure advertisements, and provide a safer experience, we use cookies. By navigating the site, you accept the disclaimer above and the collection of information through cookies.

All information provided to Investium Limited will be safeguarded and will never be shared with third parties. Visit our Terms and Conditions and Privacy Policy for more information.

Risk warning: Investing in financial instruments entails a number of risks, which can lead to the loss of part or all of your invested capital.